COPD trials recruiting in Illinois

All COPD trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
  NCT07119229 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Illinois: Chicago
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago, Winfield
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
  NCT06883305 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago, Palos Hills, Winfield
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
  NCT06878261 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Illinois: Evanston, Springfield
• An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
  NCT06035120 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago, Peoria
• Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
  NCT06891755 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 84 Years · Sex: All (male and female) · Illinois: Chicago, Peoria
• COPD Exacerbation Follow Up
  NCT07118306 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · Illinois: Park Ridge
• COPD Resources, Education, and Activity Designed for You Study
  NCT07125053 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Illinois: Chicago
• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
  NCT07059091 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · Illinois: Chicago
• Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
  NCT06122077 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · Illinois: Chicago, Deerfield, Springfield
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
  NCT06961214 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
  NCT07190209 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Illinois: Chicago, Chicago Ridge, Evanston
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
  NCT07190222 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Illinois: Champaign, Normal, Peoria
• Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
  NCT06390345 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• PiMZ Longitudinal Cohort (PiMZ Logic)
  NCT06505603 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• SPIROMICS Study of Early COPD Progression (SOURCE)
  NCT05033990 · Phase: Not specified · Ages: 30 Years to 55 Years · Sex: All (male and female) · Illinois: Chicago
• STRIVE Post-Market Registry Study
  NCT04302272 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
  NCT07610395 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Illinois: Naperville
• myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
  NCT05204888 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years and older · Sex: All (male and female) · Illinois: Chicago